Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery

Sponsor
Charles University, Czech Republic (Other)
Overall Status
Completed
CT.gov ID
NCT03638310
Collaborator
(none)
37
1
2
29
1.3

Study Details

Study Description

Brief Summary

The aim of this study is to assess effect of psychiatric profile on visual sensitivity and overall health status in patients who underwent surgery for vestibular schwannoma and were prehabituated by chemical vestibular ablation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: intratympanic application of gentamicin
  • Procedure: microsurgical removal of vestibular schwannoma
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
37 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
two groups of patients, one group prehabituated by chemical labyrintectomy, the second control group without prehabituation before the surgerytwo groups of patients, one group prehabituated by chemical labyrintectomy, the second control group without prehabituation before the surgery
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assessment of Visual Sensitivity, Psychiatric Profile and Quality of Life Following Vestibular Schwannoma Surgery in Patients Prehabituated by Chemical Vestibular Ablation
Actual Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Jun 1, 2018
Actual Study Completion Date :
Jun 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: ITG (intratympanic gentamicin) group

Patients who underwent prehabituation by gentamicin prior to surgery for vestibular schwannoma. They underwent intratympanic application of gentamicin and microsurgical removal of vest. schwannoma.

Procedure: intratympanic application of gentamicin
under local anesthesia is gentamicin instilled through tympanic membrane to tympanic cavity

Procedure: microsurgical removal of vestibular schwannoma
surgery under general anesthesia

Active Comparator: control group

patients without prehabituation before surgery. They underwent microsurgical removal of vest. schwannoma.

Procedure: microsurgical removal of vestibular schwannoma
surgery under general anesthesia

Outcome Measures

Primary Outcome Measures

  1. change of optokinetic nystagmus measurement [change of the gain of optokinetic nystagmus among 3 time points is measured: before intervention, 1 week after intervention, 3 months after intervention]

    During electronystagmography gain of optokinetic nystagmus is measured before and after the intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • T3, T4 vestibular schwannoma

  • recorded growth of a tumour

  • hearing loss greater than 50% in PTA

Exclusion Criteria:
  • T1 vestibular schwannomas

  • no growth progression

  • normal hearing

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charles University Prague Czechia 150 06

Sponsors and Collaborators

  • Charles University, Czech Republic

Investigators

  • Study Chair: Zdeněk čada, M.D., Ph.D., Charles university Prague

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Balatkova Zuzana, Zuzana Balatkova, M.D., Principal Investigator, Department of otorhinolaryngology and head and neck surgery,1st faculty of medicine Charles university and University hospital Motol, Prague, Head: Prof. Jan Plzak, M.D., Ph.D., Charles University, Czech Republic
ClinicalTrials.gov Identifier:
NCT03638310
Other Study ID Numbers:
  • 13943 FN Motol
First Posted:
Aug 20, 2018
Last Update Posted:
Aug 20, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 20, 2018